Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy

Trial Profile

Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2018

At a glance

  • Drugs Ramipril (Primary)
  • Indications Memory disorders; Radiation-induced abnormalities
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jul 2018 Planned initiation date changed from 1 Aug 2018 to 1 Oct 2018.
    • 22 Jun 2018 Planned initiation date changed from 1 Jul 2018 to 1 Aug 2018.
    • 26 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top